Why do stem cell transplant patients skip meds? new study investigates

NCT ID NCT05164835

Ongoing Knowledge-focused Sponsor: University Hospital, Limoges Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study at Limoges University Hospital looks at how well stem cell transplant patients take their medications over time. Researchers will use questionnaires and interviews with 20 patients to understand challenges like side effects and complex routines. The goal is to find ways to better support patients and improve transplant success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal key factors affecting medication adherence in stem cell transplant patients, helping improve support and outcomes.
What could go wrong: This is a small pilot study with only 20 participants at one hospital, so findings may not apply to all patients. It is observational and does not test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLOGRAFT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLOGRAFT

Contacts and locations

Locations

Limoges University Hospital

Limoges, 87042, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.